(Q36359877)

13 August 2017

1 reference

title

Cardiac biomarkers: a contemporary status report (English)

1 reference

13 August 2017

0 references

3

Eugene Braunwald

1 reference

13 August 2017

Alan S Maisel

1

1 reference

13 August 2017

Vikas Bhalla

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

24-34

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpcardio0405

13 August 2017

exact match

0 references

cites work

Diagnostic efficiency of troponin T measurements in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

Elevated Levels of Interleukin-6 in Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Chest pain centers: diagnosis of acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

B-type natriuretic peptide in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Relationship between plasma level of brain natriuretic peptide and myocardial infarct size

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Independent prognostic value of elevated C-reactive protein in unstable angina

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Soluble CD40 Ligand in Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Prognostic value of placental growth factor in patients with acute chest pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Soluble CD40L: risk prediction after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0405

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0405

1 reference

Dimensions Publication ID

13 August 2017

1022160093

0 references

Fatcat ID

release_dd6x4f3egvf7xi63igtgelvlze

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dd6x4f3egvf7xi63igtgelvlze

24 November 2022

mapped directly with Wikidata item

1 reference